Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres. - Wikidata - awgldk - TriplyDB

Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres.

Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres.

http://www.wikidata.org/entity/Q33438872

about

Expanding access to Transfusion Medicine and improving practice: guidelines, patient blood management, protocols and products.

P2860

Q50094128-B95AB001-B403-4DB1-BF7C-55DC1255F7E2

P2860

Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres.

http://www.wikidata.org/entity/Q33438872

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Audit of provincial IVIG Reque ...... Ontario tertiary care centres.

@ast

Audit of provincial IVIG Reque ...... Ontario tertiary care centres.

@en

type

label

Audit of provincial IVIG Reque ...... Ontario tertiary care centres.

@ast

Audit of provincial IVIG Reque ...... Ontario tertiary care centres.

@en

prefLabel

Audit of provincial IVIG Reque ...... Ontario tertiary care centres.

@ast

Audit of provincial IVIG Reque ...... Ontario tertiary care centres.

@en

P1433

Q33438872-386B7BED-80B0-4822-A8DF-42FD77B6D6D6

P1476

Q33438872-0B8DB308-9149-4688-BE08-F1A9D18C6D3B

P2093

Q33438872-4640D832-24B2-47BC-B3E8-96DB653F30BB

Q33438872-477C8F46-0E04-4BC9-86AA-8A0E09538BE9

Q33438872-4C7D98E4-D803-4CE0-B1C8-D4C2A95FD2F4

Q33438872-5B85429B-CB47-49AA-B349-345F265A9168

Q33438872-5FFB1826-1ED8-4467-80E3-D6D7C90E2D2D

Q33438872-62F735F0-53D8-4BB9-AB12-8073531156DF

Q33438872-78BDF44D-DDAA-4D5F-A5A8-E8B8BF3BA452

Q33438872-8CCAB601-8E73-4732-BB7F-6E3A2D403FB5

Q33438872-91723C30-E2B9-4844-A4D9-635C1B470071

Q33438872-F75E85EF-03F4-4B4D-AF96-6311D7B25B5A

P2860

Q33438872-0779CE36-4DAE-463C-B7B5-DC691C7D53B8

Q33438872-09266447-79F3-4F76-80DF-5B06D6F22C0C

Q33438872-0ED00692-368F-4F60-9331-66EA9DB50152

Q33438872-21E697D2-6842-4804-8DB1-29DBFC52BC6B

Q33438872-2705BDC4-F92F-4A7B-8822-709DF3D2D945

Q33438872-3A4B145B-0DD4-41A0-B1F9-8CEBDD1E4972

Q33438872-3C946627-55C6-4171-ABB3-4CDE8BE54204

Q33438872-4466428F-AA55-4FB6-9919-DC62633D407C

Q33438872-4C279664-0BA5-4503-9D15-71E4D2D0870C

Q33438872-4F706C73-A188-4D5B-89BD-6B2FEF8405F0

P304

Q33438872-D52035EA-2092-4ADB-AE71-DBF5E64DF0E4

P31

Q33438872-BCFE9B65-A47C-4773-8C49-E6B35AFC5536

P356

Q33438872-26CE488E-5CD7-4380-B530-DCC679E33818

P433

Q33438872-F775376B-B2C3-4FD0-AECA-18541B1EF051

P478

Q33438872-710903F0-1ACD-48A2-85E5-276A85A5A8D2

P577

Q33438872-D4BE9491-7688-4F23-B681-300B9EBE1C45

P698

Q33438872-40D813C0-AE91-47A1-9194-A9211AF974F7

P356

P1433

Transfusion Medicine

P1476

Audit of provincial IVIG Reque ...... Ontario tertiary care centres.

@en

P2093

A Traore

http://www.w3.org/2001/XMLSchema#string

A W Shih

http://www.w3.org/2001/XMLSchema#string

C Armali

http://www.w3.org/2001/XMLSchema#string

C Diep

http://www.w3.org/2001/XMLSchema#string

C M Hillis

http://www.w3.org/2001/XMLSchema#string

E Jamula

http://www.w3.org/2001/XMLSchema#string

J Doherty

http://www.w3.org/2001/XMLSchema#string

N M Heddle

http://www.w3.org/2001/XMLSchema#string

N Shah

http://www.w3.org/2001/XMLSchema#string

Y Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-inflammatory actions of intravenous immunoglobulin

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.

Thrombotic complications after intravenous immunoglobulin therapy in two patients.

Guidelines on the use of intravenous immune globulin for hematologic conditions.

Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group.

The Canadian Choosing Wisely campaign: the Canadian Hematology Society's top five tests and treatments.

Guidelines on the use of intravenous immune globulin for neurologic conditions.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

Risks associated with the use of intravenous immunoglobulin.

P304

122-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TME.12391

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28144996

http://www.w3.org/2001/XMLSchema#string